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RESEARCH ARTICLE
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involve CD103+ gut dendritic cells (DCs), yet their role in commensal-reactive pTreg development is
unclear. Using two Helicobacter-specific T cell receptor (TCR) transgenic mouse lines, we found that
both CD103+ and CD103– migratory, but not resident, DCs from the colon-draining mesenteric
lymph node presented Helicobacter antigens to T cells ex vivo. Loss of most CD103+ migratory
DCs in vivo using murine genetic models did not affect the frequency of Helicobacter-specific
pTreg cell generation or induce compensatory tolerogenic changes in the remaining CD103– DCs.
By contrast, activation in a Th1-promoting niche in vivo blocked Helicobacter-specific pTreg
generation. Thus, these data suggest a model where DC-mediated effector T cell differentiation is
‘dominant’, necessitating that all DC subsets presenting antigen are permissive for pTreg cell
induction to maintain gut tolerance.

Introduction
The intestinal immune system is required to balance maintaining tolerance to commensal bacteria
while preserving the capability of mounting an inflammatory response to pathogenic bacteria. Commensal bacterial induction of tolerogenic peripheral regulatory T (pTreg) cells, and not pro-inflammatory effector T cells, appears to be important for preserving immune homeostasis and health and
preventing the development of inflammatory bowel disease (IBD) (Blander et al., 2017; Imam et al.,
2018; Shale et al., 2013).
A substantial body of evidence suggests that the process by which naı̈ve CD4+ T cells are
selected to be pTreg vs effector T cells is directed by specific conventional dendritic cell (cDC) subsets. For example, cDC1s direct the differentiation of Th1 T cells through their production of IL-12.
In a similar fashion, subsets of cDC2s have been shown to be important for both Th2 and Th17 differentiation (Durai and Murphy, 2016).
In the intestine, CD103+ cDCs comprising both CD103+ CD11b– cDC1s and CD103+ CD11b+
cDC2s are commonly thought to induce the differentiation of pTreg cells from naı̈ve T cells
(Hasegawa and Matsumoto, 2018; Scott et al., 2011; Takenaka and Quintana, 2017;
Tanoue et al., 2016). The studies that initially characterized this subset as the predominant pTreg
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cell-inducting subset of cDCs were primarily done in vitro and determined that the pTreg cell-inducing properties of mixed CD103+ CD11b– cDC1 and CD103+ CD11b+ cDC2 populations were dependent on TGF-b, the retinoic acid-producing enzyme retinaldehyde dehydrogenase (RALDH), and the
tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) (Coombes et al., 2007;
Huang et al., 2013; Matteoli et al., 2010; Sun et al., 2007). Importantly, the early studies examining CD103+ cDCs (Coombes et al., 2007; Sun et al., 2007) were performed before it was appreciated that this population included both cDC1s and a subset of cDC2s. These early studies also did
not discriminate between migratory and resident cDC subsets in the mesenteric lymph nodes (MLN)
or between CD11c+ cDCs and macrophages in the colon lamina propria (cLP), therefore confounding comparisons of CD103+ and CD103– cDC subsets in pTreg induction (Coombes et al., 2007;
Huang et al., 2013; Matteoli et al., 2010; Sun et al., 2007). In addition to these in vitro experiments, in vivo studies have suggested that CD103+ cDC1s and cDC2s are important for ovalbumin
(OVA)-specific pTreg cell differentiation in a model of oral tolerance. Esterhazy et al. used
Zbtb46Cre::Irf8fl/fl mice to deplete cDC1s and Mazzini et al. used Itgax-Cre::Gja1fl/fl mice to delete
Connexin 43 in all CD11c+antigen presenting cells (APCs), finding a defect in antigen presentation
by small intestine CD103+ CD11b+ cDC2s; however, the conclusion that CD103+ cDC1s and cDC2s
are critical may have been confounded by the deletion of these targeted genes in all cDC subsets
(Esterházy et al., 2016; Mazzini et al., 2014). Finally, Welty et al. showed that depletion of CD103+
cDC1s and cDC2s in CD207-DTA::Batf3–/– mice resulted in decreased polyclonal CD4+ T cell numbers in the small intestine lamina propria, including Treg cells (Welty et al., 2013). Although this latter study cannot address whether CD103+ cDC1s and cDC2s contributed to pTreg cell induction vs
maintenance, these data add to the body of literature supporting the notion that CD103+ cDC1s
and cDC2s are important for pTreg cell induction.
Recently, this prevailing concept that CD103+ cDC1s and cDC2s are the primary inducers of
pTreg cells in the intestine has been challenged. One study of colonic tolerance to OVA enema
showed that protection against delayed-type hypersensitivity (DTH) could be mediated by CD103–
CD11b+ cDC2s (Veenbergen et al., 2016). As the draining LN of OVA enema are the iliac and caudal LNs, which naturally lack CD103+ CD11b+ cDC2s, the use of Batf3–/– mice eliminated the only
CD103+ cDCs in these LNs, the CD103+ cDC1s. The notion that CD103– CD11b+ cDC2s are sufficient for inducing OVA-specific Treg cells was supported by in vitro experiments, but in vivo OVAspecific Treg induction after OVA enema in Batf3–/– mice was not assessed. Similarly, we previously
found that colonic Helicobacter-specific pTreg cell differentiation was unaffected in Batf3–/– mice
(Nutsch et al., 2016). However, one caveat of our study is that Batf3-deficiency may only result in a
partial decrease in cDC1s in intestinal tissues (Tussiwand et al., 2012) and does not eliminate
CD103+ CD11b+ cDC2s in the MLN draining more proximal portions of the GI tract. Another study
found that MHC Class II expression in CX3CR1+ mononuclear phagocytes, thought to be a subset
apart from CD103+ cDC1s and cDC2s (Bogunovic et al., 2009), is required for pTreg cell induction
in oral tolerance and that CX3CR1+ mononuclear phagocytes are required for pTreg cell differentiation in commensal tolerance in Rag2–/– host mice (Kim et al., 2018). These studies therefore argue
that non-CD103+ DCs are important or redundant for Treg cell development. However, it is possible
that the ‘tolerogenic’ cDC subset differs for oral or per rectum administered soluble proteins vs. naturally colonized commensal bacterial antigens. Thus, the importance of cDC subsets for the induction of intestinal pTreg cells remains an open area of study (Mowat, 2018).
Previously, we identified two colonic T cell clones (CT2 and CT6) that undergo pTreg cell differentiation in response to distinct Helicobacter (H.) species, H. typhlonius or H. apodemus, respectively
(Chai et al., 2017). Colonic Helicobacter species reside in close proximity to the intestinal epithelium
within the mucous layer in the crypts (Recordati et al., 2009) and are classified as pathobionts that
cause inflammation in susceptible hosts, yet are pervasive in healthy hosts (Fox et al., 1999;
Taylor et al., 2007). At homeostasis, Zbtb46+ cDCs are essential for presenting H. typhlonius and H.
apodemus to naı̈ve T cells in the colon-draining distal MLN (dMLN); naı̈ve Helicobacter-specific T
cells are not activated in vivo in the absence of cDCs (Chai et al., 2017; Lathrop et al., 2011;
Nutsch et al., 2016). However, the specific cDC subset that presents Helicobacter antigens to naı̈ve
T cells and mediates pTreg cell selection remains unknown.
Here, we examine the role of cDC subsets in presenting antigens from Helicobacter to naı̈ve T
cells and how they influence naı̈ve T cell differentiation. Our data argue against the hypothesis that
CD103+ cDC1s and cDC2s represent specialized cDC subsets required for presentation of gut
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commensal antigens and pTreg cell induction. Rather, our data support the notion that unlike certain
cDC functions, induction of commensal-specific Treg cells in the periphery is not restricted to a specific migratory cDC subset. These data support a model in which pTreg cell development is ‘recessive’ such that all cDCs presenting cognate antigen to a given naı̈ve T cell must be permissive for
the induction of FOXP3, and that the presence of antigen-carrying cDCs that induce canonical effector T cell development ‘dominantly’ blocks pTreg cell generation.

Results
Migratory cDCs present Helicobacter antigens during homeostasis
If a specific subset of cDCs facilitates the conversion of commensal-specific T cells into pTreg cells,
then this subset should present Helicobacter antigens on MHC Class II. We therefore sought to
determine the cDCs that present Helicobacter antigens in vivo. First, we asked whether Helicobacter
antigens are presented by cDCs resident in the dMLN vs those that migrate from the colon. Lymph
node resident cDCs may acquire soluble antigens either from lymphatic drainage from the colon or
transfer from migratory cDCs (Allan et al., 2006; Hor et al., 2015; Sixt et al., 2005). In contrast,
migratory cDCs have been shown to pick up antigens in the intestine lamina propria through a variety of mechanisms and then move through afferent lymphatics to the draining MLN (Cerovic et al.,
2013; Farache et al., 2013; Mazzini et al., 2014; McDole et al., 2012; Worbs et al., 2006).
To directly examine which of these cDC subsets are loaded with Helicobacter antigen in vivo, we
sorted resident (MHC IIint CD11chi) and migratory (MHC IIhi CD11cint) cDCs (Satpathy et al., 2012)
from the dMLN and co-cultured them with naı̈ve Helicobacter-specific T cell receptor (TCR) transgenic cells that recognize H. typhlonius (CT2) or H. apodemus (CT6) (Figure 1—figure supplement
1A; Chai et al., 2017). TCR activation was assessed by CD25 upregulation. We observed that migratory cDCs were much more efficient than resident cDCs at activating both CT2 and CT6 TCR transgenic T cells, as assessed by the percentage of activated CD25+ cells and CD25 median
fluorescence intensity (MFI), a measurement for magnitude of activation within individual cells
(Figure 1A). When exogenous autoclaved Helicobacter antigens were added to the cultures, resident cDCs were actually more efficient than migratory cDCs at activating naı̈ve T cells, confirming
that resident cDCs are fully capable of antigen uptake, processing, and presentation (Figure 1B).
Migratory cDC stimulation of T cells was MHC Class II-dependent, as it could be blocked by addition
of monoclonal anti-MHC Class II blocking antibody to the culture (Figure 1—figure supplement
1B). In summary, these ex vivo data show that migratory, but not resident, cDCs in the dMLN present Helicobacter antigens during homeostasis.
We then addressed whether genetic ablation of a receptor necessary for efficient cDC migration
would affect CT2 and CT6 T cell activation in vivo. Ccr7–/– mice lack a critical chemokine receptor for
cDC trafficking to the lymph node and therefore lack most migratory cDCs in the dMLN
(Mikulski et al., 2015; Ohl et al., 2004; Satpathy et al., 2012). One week after transfer of naı̈ve
TCR transgenic cells into Ccr7+/– or Ccr7–/– mice, we observed a striking decrease in T cell activation,
as measured by the number of recovered CT2 and CT6 cells in the dMLN after adoptive transfer, as
well as a decrease in the induction of Foxp3+ CT2 and CT6 cells (Figure 1C). A caveat of these
results is that CCR7 is required for the development of normal lymphoid organ architecture and T
cell entry into lymph nodes, resulting in altered immune responses in host mice (Förster et al.,
2008). Nevertheless, these in vivo Ccr7–/– results are consistent with the ex vivo cDC results
described above, and together these data demonstrate an important role of migratory cDCs in the
activation of naı̈ve Helicobacter-specific T cells.

All migratory cDC subsets present Helicobacter antigens
We next asked which subset(s) of migratory cDCs are capable of activating naı̈ve CT2 and CT6 T
cells. For these studies, we sorted single positive CD103+ CD11b– (CD103+ SP) cDC1, double positive CD103+ CD11b+ (DP) cDC2, and single positive CD103– CD11b+ (CD11b+ SP) cDC2 subsets of
migratory cDCs. We assessed cDC purity using Zbtb46GFP mice (Figure 2—figure supplement 1A),
which express GFP in cDC lineage cells as well as monocyte-derived cDCs during inflammation, but
not in macrophages (Satpathy et al., 2012). This revealed that about 15–25% of CD103– CD11b+
sorted cells are F4/80lo/intZbtb46GFP– (Figure 2—figure supplement 1A) and likely represent a
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Figure 1. Migratory conventional dendritic cells (cDCs) present Helicobacter antigens to naı̈ve T cells. (A) Migratory cDCs present endogenously
loaded Helicobacter antigens to T cells. Resident (MHCIIint CD11chi) or migratory (MHCIIhi CD11cint) cDCs from the distal mesenteric lymph
node (dMLN) were cultured with naı̈ve (CD44lo CD62Lhi CD4+) CT2 or CT6 T cells for 2 days. The percentage of CT2 and CT6 T cells that upregulated
CD25 and the CD25 median fluorescence intensity (MFI) of CD25+ cells were analyzed by flow cytometry (expt. = 3). (B) Both resident and migratory
cDCs can present exogenous Helicobacter antigens. dMLN resident and migratory cDCs were cultured as in (A) with the addition of autoclaved isolates
of H. typhlonius (CT2) or H. apodemus (CT6) (expt. = 3). (C) Migratory cDCs are necessary for CT2 and CT6 activation in vivo. Naı̈ve CT2 or CT6 (5 
104) were injected into littermate Ccr7+/– or Ccr7–/– mice. Transferred cells in the dMLN were analyzed 1 week later for total cells recovered and
Foxp3IRES-GFP or Thy1.1 expression (expt. = 3). Each dot represents an independent experiment except in (C), where each dot represents one mouse.
Mean ± SEM shown. p-values from Student’s t-test (A–C) excluding no cDC condition (A); *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. The following
figure supplement is available for Figure 1—figure supplement 1.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Migratory conventional denditic cells (cDCs) present Helicobacter antigens to naı̈ve T cells.
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macrophage subset with cDC-like antigen presentation functionality (Cerovic et al., 2014;
Satpathy et al., 2012). As our previous study using Zbtb46DTR mice suggested that Zbtb46– cells
played a minor to negligible role in presentation of Helicobacter antigens in vivo (Nutsch et al.,
2016), we expected that these contaminants would not activate CT2/CT6 in our in vitro analysis of
CD103– CD11b+ cDC2s.
Our previous studies showed a defect in CT2 and CT6 pTreg cell differentiation in Itgax-Cre::
Notch2fl/fl (Notch2-DDC) mice (Nutsch et al., 2016). Disruption in NOTCH2 signaling in cDCs results
in loss of CD103+ CD11b+ DP cDC2s in the MLN, although development and function of other cDC
subsets are also altered in these mice (Lewis et al., 2011; Satpathy et al., 2013). Based on these
previous data and other studies (Welty et al., 2013), we predicted that DP cDC2s would be the primary cDC subset presenting Helicobacter antigens in the dMLN. Unexpectedly, we observed that at
least some members of all three subsets of migratory cDCs constitutively presented Helicobacter
antigens to naı̈ve CT2 and CT6 T cells using the ex vivo culture approach described above (Figure 2,
Figure 2—figure supplement 1B). Although DP cDC2s tended to activate both CT2 and CT6 naı̈ve
T cells to a greater degree than the other two subsets, DP cDC2s only constitute about 15% of
migratory cDCs in the dMLN and thus may not represent the dominant cDC subset inducing naı̈ve T
cell activation in vivo (Figure 2—figure supplement 1C). All three subsets of migratory cDCs had
comparable naı̈ve T cell activating potential, as demonstrated by coculturing cDCs with naı̈ve OT-II T
cells and varying concentrations of OVA peptide (Figure 2—figure supplement 1D). Thus, contrary
to our hypothesis, these in vitro data show that all migratory cDC subsets carry Helicobacter antigens from the colon and can present the antigens to naı̈ve CT2 and CT6 T cells in the dMLN.

cDC1s are not required for Helicobacter-specific pTreg cell
differentiation in vivo
We next used mice genetically deficient in cDC subsets to study pTreg cell differentiation in vivo.
Based on prior studies showing the importance of cDC1s in oral tolerance (Esterházy et al., 2016;
Mazzini et al., 2014), we previously studied cDC1-deficient Batf3–/– mice (Nutsch et al., 2016). We
found that CT2 and CT6 pTreg cell development were unchanged in Batf3–/– mice, consistent with
studies examining DTH responses after OVA enema (Veenbergen et al., 2016). However, one
caveat of Batf3–/– mice is that a large number of cDC1s remain in mucosal tissue and specifically in
the dMLN due to the compensatory expression of Batf in a pro-inflammatory environment
(Tussiwand et al., 2012; Figure 3—figure supplement 1A). It was therefore possible that cDC1s in
Batf3–/– mice were sufficient to maintain pTreg cell selection.
In comparison to Batf3–/– mice, mice which have a 149 bp deletion in the Irf8 enhancer including
the +32 kb BATF3-binding enhancer element (Irf8D149en/D149en, formerly Irf8 +32 5’–/–Durai et al.,
2019) showed a much greater reduction of the number of cDC1s in the dMLN (Figure 3A).
Irf8D149en/D149en mice did not have a decrease in total migratory cDC numbers, as there were
increased numbers of CD103+ CD11b+ and to a lesser extent CD103– CD11b+ cDC2s in the absence
of cDC1s (Figure 3A). The frequency of polyclonal colonic CD4+ FOXP3+ T cells was unchanged in
Irf8D149en/D149en mice (Figure 3B). Additionally, the proportion of colonic pTreg cells marked by low
HELIOS expression (Thornton et al., 2010) was unchanged in Irf8D149en/D149en mice (Figure 3B).
Although low HELIOS expression is an imperfect marker for pTreg cells, these data suggest that the
proportion of bacteria-specific Treg cells is not grossly altered by the loss of CD103+ CD11b–
cDC1s. Finally, both FOXP3– and FOXP3+ colonic polyclonal T cells exhibited significant decreases in
TBET (Tbx21) expression, confirming that cDC1s are important for the induction of Th1 and TBET+
Treg cells (Figure 3B). Conventional T cells showed increased GATA3 expression, suggesting that
compensatory Th2 development occurs with the loss of cDC1s and decrease in Th1 development
(Figure 3B). RORgt (Rorc) expression in colonic conventional T cells remained low after the loss of
cDC1s. Together, these data suggest that loss of cDC1s selectively increases colonic Th2 frequencies
at the expense of Th1 cells, while polyclonal peripheral FOXP3+ Treg cell proportions are
maintained.
To assess the effects of cDC1 loss on commensal antigen-specific pTreg cell development, we
transferred naive CT2 and CT6 cells into 3–4-week-old Irf8D149en/D149en mice. We used 3–4-week-old
recipient mice throughout our work to model the natural timeframe of pTreg induction to commensal bacteria as well as food exposure, which occurs at weaning (Atarashi et al., 2011; Nutsch et al.,
2016). Moreover, we previously found that CT2 and CT6 pTreg cell differentiation decreases in mice
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Figure 2. Multiple subsets of migratory conventional dendritic cells (cDCs) present Helicobacter antigens to naı̈ve
T cells at homeostasis. All three main subsets of migratory cDCs present endogenous Helicobacter antigens to T
cells ex vivo. Migratory CD103+ CD11b– cDC1s (CD103+ SP), CD103+ CD11b+ cDC2s (DP), or CD103– CD11b+
cDC2s (CD11b+ SP) were sorted from the distal mesenteric lymph node (dMLN) and cultured with naı̈ve CT2 and
CT6 T cells as in Figure 1A (expt. = 5–6). Each dot represents an individual experiment. Mean ± SEM is shown.
p-values from Tukey’s multiple comparisons test excluding no cDC condition; *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001. The following figure supplement is available for Figure 2—figure supplement 1.
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Figure supplement 1. Multiple subsets of migratory conventional dendritic cells (cDCs)
present Helicobacter antigens to naı̈ve T cells at homeostasis.
Figure supplement 1—source data 1. Migratory cDC1s are increased in the dMLN of wild-type mice relative to
the proximal MLN (pMLN), Figure 2—figure supplement 1C raw data.
Figure supplement 1—source data 2. Comparable T cell activation by all subsets of migratory conventional dendritic cells (cDCs), Figure 2—figure supplement 1D raw data.
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Figure 3. CD103+ CD11b– cDC1s are not required for Helicobacter-specific peripheral regulatory T (pTreg) differentiation in vivo. (A) Deficiency of
CD103+ CD11b– cDC1s in the distal mesenteric lymph node (dMLN) of Irf8D149en/D149en mice. Representative fluorescence-activated cell sorting (FACS)
plot and quantification of migratory conventional dendritic cell (cDC) subsets in the dMLN of littermate Irf8+/D149en and Irf8D149en/D149en mice (expt. = 3,
n = 9–11). (B) Decreased frequency of Th1 and TBET+ Treg cells in the colon lamina propria (cLP) of Irf8D149en/D149en mice. Representative FACS plots
Figure 3 continued on next page
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Figure 3 continued
and intracellular staining quantification of FOXP3, HELIOS, TBET, RORgt, and GATA3 expression in cLP are shown (expt. = 2). (C and D) Helicobacterspecific T cell activation and Treg cell differentiation are not dramatically altered in cDC1-deficient mice. Congenically marked 5  104 naı̈ve CT2 (C) or
105 naı̈ve CT6 (D) were transferred into littermate Irf8+/D149en and Irf8D149en/D149en mice and analyzed for Foxp3IRES-GFP or Thy1.1 expression and cell trace
violet (CTV) dilution in the dMLN after 7 days (expt. = 3 each). (E) T cell activation and Treg cell differentiation in oral tolerance are not altered by loss
of cDC1s. 5  104 naı̈ve OT-II cells were transferred into littermate Irf8+/D149en and Irf8D149en/D149en mice, which were gavaged with 50 mg OVA on
consecutive days and analyzed as in (C and D) (expt. = 5). Each dot represents an individual mouse. Mean ± SEM (A–E) or + SEM (A, right) shown.
p-values from Sidak’s multiple comparisons test (A, middle), two-way ANOVA subset/genotype interaction (A, right); Student’s t-test (B, middle), Sidak’s
multiple comparisons test (B, right); Student’s t-test (C–E); *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. The following figure supplement is available
for Figure 3—figure supplement 1. The following source data are available for (A–E): Figure 3—source data 1 (A, right).
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. Deficiency of CD103+ CD11b– cDC1s in the distal mesenteric lymph node (dMLN) of Irf8D149en/D149en mice, Figure 3A raw data.
Figure supplement 1. CD103+ CD11b– cDC1s are not required for Helicobacter-specific peripheral regulatory T (pTreg) differentiation in vivo.
Figure supplement 1—source data 1. Frequency, but not number, of CD103+ cDC1s are reduced in the distal mesenteric lymph
node (dMLN) of Batf3–/– mice, Figure 3—figure supplement 1A raw data.

greater than 5 weeks of age (Nutsch et al., 2016). After such transfer, both CT2 and CT6 exhibited
small decreases in pTreg cell differentiation in Irf8D149en/D149en mice, but this was not proportional to
the loss of cDC1s (Figure 3C,D). The loss of cDC1s had a differential effect on CT2 and CT6 antigen
recognition and activation, as CT2 showed decreased, and CT6 showed increased, cell trace
violet (CTV) dilution in Irf8D149en/D149en mice (Figure 3C,D). Under these conditions, CTV dilution in
CT2 and CT6 is entirely dependent on Helicobacter – see Figure 4A in Chai et al., 2017. Thus,
cDC1s may be more involved in H. typhlonius antigen presentation to CT2 than H. apodemus presentation to CT6, but they are not essential for Helicobacter-specific pTreg cell differentiation. Furthermore, the selective expansion of DP cDC2s in Irf8D149en/D149en mice and the increase in CTV
dilution particularly in Foxp3– CT6 cells may indicate that DP cDC2s are more capable of antigen
presentation to naı̈ve CT6 cells than CT2 cells, and that this expansion of DP cDC2s is detrimental to
CT6 pTreg cell differentiation.
Since it had previously been reported that Treg cell differentiation was diminished in Zbtb46Cre::
Irf8fl/fl mice in a model of oral tolerance (Esterházy et al., 2016), we asked whether this was also
true for Irf8D149en/D149en mice. Similar to the dMLN, CD103+ SP cDC1s were significantly reduced
with a compensatory increase in the CD103+ CD11b+ DP cDC2 population in the proximal MLN
(pMLN: all MLN except for dMLN) of Irf8D149en/D149en mice (Figure 3—figure supplement 1B). To
assess pTreg differentiation in response to oral antigens, we transferred OT-II T cells into OVA-gavaged 3–4-week-old mice to maintain consistency with the CT2/CT6 transfer experiments, which are
affected by host age (Nutsch et al., 2016), as well as to model oral antigen exposure that takes
place at weaning. In contrast to a prior study (Esterházy et al., 2016), we did not see a change in
the frequency of whole MLN Foxp3+ cells among transferred naı̈ve OT-II cells in Irf8D149en/D149en vs
Irf8+/D149en mice fed OVA (Figure 3E). We did observe a trend toward decreased T cell activation in
Irf8D149en/D149en mice as measured by CTV dilution, similar to what we saw for CT2 (Figure 3C,E).
The difference between this and the previous study could be due to the use of younger vs older 7–
12-week-old hosts (Esterházy et al., 2016), or to the nature of the Irf8 gene locus modification in
cDCs between the two mouse lines: Zbtb46Cre::Irf8fl/fl mice lack IRF8 expression in all cDCs (but with
incomplete penetrance), while Irf8D149en/D149en mice lack IRF8 expression only in BATF3-dependent
cDC1s (Durai et al., 2019; Loschko et al., 2016). In summary, our data suggest that cDC1s can contribute to the antigen presentation of oral as well as bacterial antigens but are not required for
pTreg cell differentiation to those antigens.

CD103+ CD11b+ cDC2s are not required for Helicobacter-specific pTreg
cell differentiation in vivo
We next asked whether the CD103+ CD11b+ (DP) cDC2 subset is required for Helicobacter-specific
pTreg cell differentiation, as our in vitro data showed that CT2 and CT6 are most efficiently activated
by this subset (Figure 2). Others have shown that this subset is preferentially diverted from the lymphatics to the mesenteric fat after Yersinia pseudotuberculosis infection, altering the induction of tolerance to commensal microbiota (Fonseca et al., 2015). We previously showed that loss of this
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subset in Notch2-DDC mice results in decreased in vivo CT2 and CT6 pTreg cell differentiation
(Nutsch et al., 2016). To confirm these results in another model of DP cDC2 deletion, we transferred naı̈ve CT2 and CT6 T cells into Itgax-Cre::Irf4fl/fl (Irf4-DDC) mice, which exhibit significantly
reduced DP cDC2s in the dMLN (Figure 4—figure supplement 1A; Persson et al., 2013). Similar to
Notch2-DDC mice, CT2 Foxp3– cells trended toward increased antigen stimulation as measured by
CTV dilution (Figure 4—figure supplement 1B; Nutsch et al., 2016). However, CT2 and CT6 pTreg
cell development were unchanged in Irf4-DDC mice in contrast to Notch2-DDC mice (Figure 4—figure supplement 1B,C). This discrepancy suggests that the effects of these genetic modifications on
pTreg cell generation were not related to the loss of DP cDC2s, which occurred in both Notch2-DDC
and Irf4-DDC mice, but rather to differences arising from deletion of these genes in the remaining
cDCs. We therefore turned to a third genetic model of DP cDC2 depletion that does not require
Itgax-Cre mediated gene deletion in all cDCs, but instead uses diphtheria toxin driven by the human
langerin promoter (CD207-DTA; formerly huLangerin-DTA) (Welty et al., 2013).
We first confirmed that DP cDC2s are missing in the dMLN in CD207-DTA mice, as it was previously only reported for the whole MLN (Figure 4A; Welty et al., 2013). Since the reduction in
cDC2s in CD207-DTA mice can be difficult to appreciate due to spillage of single positive cells into
the DP gate, we used additional markers to more specifically quantify DP cDC2s in CD207-DTA mice
(Figure 4—figure supplement 1D). In the SIRPa+ cDC2 population, DP cells were markedly reduced
in CD207-DTA mice. Similarly, SIRPa+ cDC2s with CD101 expression, which in combination with
CD103+ is a marker for DP cells (Bain et al., 2017), were also significantly reduced in CD207-DTA
mice.
Analysis of polyclonal colon T cells in CD207-DTA mice revealed that there was neither a significant increase in Treg cells nor the proportion of HELIOSlo putative pTreg cells (Figure 4B). In contrast to previous reports showing that CD103+ CD11b+ cDC2s are important for Th17 differentiation
in the small intestine lamina propria (Persson et al., 2013; Welty et al., 2013), CD207-DTA mice
did not show a decreased percentage of polyclonal Th17 cells or RORgt+ Treg cells in the cLP, the
former of which was low at homeostasis (Figure 4B). Additionally, the expression of other T cell lineage transcription factors in both FOXP3– and FOXP3+ T cells were unchanged in colonic polyclonal T
cells of CD207-DTA mice (Figure 4B). These data suggest that CD103+ CD11b+ cDC2s, which constitute a small proportion of cDCs within colon-associated dMLN, are not required for colonic T cell
differentiation/maintenance at homeostasis.
When naı̈ve CT2 and CT6 T cells were transferred into CD207-DTA mice, they differentiated into
Treg cells normally (Figure 4C,D). In addition, T cell activation of both Foxp3– and Foxp3+ CT2 and
CT6 were unchanged in CD207-DTA mice, as measured by CTV dilution (Figure 4C,D). Since DP
cDC2s constitute a small percentage of cDCs in the dMLN but a much greater percentage in the
pMLN, we wondered whether loss of these cells would have a greater effect on Treg cell development in the small-intestine-draining MLN (Figure 2—figure supplement 1C). As expected, CD103+
CD11b+ cDC2s were reduced in the pMLN of CD207-DTA mice, with a compensatory increase in
the frequency of CD103+ CD11b– cDC1s (Figure 4—figure supplement 1E). We therefore examined Treg cell development in oral tolerance after OVA feeding. Surprisingly, given that others have
reported a critical role for CD103+ CD11b+ DP cDCs in oral tolerance Treg cell development
(Mazzini et al., 2014), OT-II pTreg cell differentiation was significantly increased in CD207-DTA
mice without changing T cell activation, indicating that loss of DP cDC2s enhances pTreg cell differentiation in oral tolerance (Figure 4E). In summary, these data suggest that DP cDC2s are not
required for Helicobacter- or OVA-specific Treg cell generation in the MLN.

Decreased CD103+ cDC1 and cDC2 cell number does not impact
Helicobacter-specific pTreg cell differentiation in vivo
At least one study suggested that CD103+ cDCs collectively, encompassing both cDC1s and DP
cDC2s, are responsible for in vivo Treg cell generation/maintenance in the small intestine
(Welty et al., 2013). This study utilized CD207-DTA::Batf3–/–mice to delete CD103+ cDCs. However,
as in Batf3–/– mice, we have observed that a substantial number of cDC1s can sometimes remain in
CD207-DTA::Batf3–/– mice (Figure 5—figure supplement 1A). When naı̈ve CT2 and CT6 T cells
were transferred into CD207-DTA::Batf3–/– mice, they showed no decrease in pTreg cell differentiation (Figure 5—figure supplement 1B,C). Both CT2 and CT6 showed decreased T cell activation as
measured by CTV dilution (Figure 5—figure supplement 1B,C). Thus, partial deletion of CD103+
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Figure 4. CD103+ CD11b+ cDC2s are not necessary for in vivo Helicobacter-specific peripheral regulatory T (pTreg) differentiation. (A) Double positive
CD103+ CD11b+ (DP) cDC2s are lost in the distal mesenteric lymph node (dMLN) of CD207-DTA mice. Representative fluorescence-activated cell
sorting (FACS) plot and quantification of migratory conventional dendritic cell (cDC) subsets in the dMLN of littermate control (WT, Batf3+/–, or Irf8+/
D149en
mice) and CD207-DTA mice (expt. = 7, n = 10). (B) The frequencies of T cell subsets in the colon lamina propria (cLP) are unchanged in CD207Figure 4 continued on next page
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Figure 4 continued
DTA mice. Representative FACS plots and intracellular staining quantification of FOXP3, HELIOS, TBET, RORgt, and GATA3 expression in cLP are
shown (expt. = 3). (C and D) Helicobacter-specific T cell activation and Treg cell differentiation are not altered in DP cDC2-deficient mice. Congenicallymarked 5  104 naı̈ve CT2 (C) or 105 naı̈ve CT6 (D) were transferred into littermate control and CD207-DTA mice and analyzed for Foxp3IRES-GFP or Thy1.1
expression and cell trace violet (CTV) dilution in the dMLN after 7 days (expt. = 8, 7, respectively). (E) Treg cell differentiation in oral tolerance is
increased with the loss of DP cDC2s. 5  104 naı̈ve OT-II cells were transferred into littermate WT and CD207-DTA mice, which were gavaged with 50
mg OVA on consecutive days and analyzed as in (C and D) (expt. = 5). Each dot represents an individual mouse. Mean ± SEM (A–E) or + SEM (A, right).
p-values from Sidak’s multiple comparisons test (A, middle), two-way ANOVA subset/genotype interaction (A, right); Student’s t-test (B, middle), Sidak’s
multiple comparisons test (B, right); Student’s t-test (C–E); *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. The following figure supplement is available
for Figure 4—figure supplement 1. The following source data are available for (A–E): Figure 4—source data 1 (A, right).
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Double positive CD103+ CD11b+ (DP) cDC2s are lost in the distal mesenteric lymph node (dMLN) of CD207-DTA mice, Figure 4A raw
data.
Figure supplement 1. CD103+ CD11b+ cDC2s are not necessary for in vivo Helicobacter-specific peripheral regulatory T (pTreg) differentiation.

cDCs resulted in decreased Helicobacter antigen presentation without affecting pTreg cell
differentiation.
To more efficiently delete CD103+ cDCs in the dMLN, we bred Irf8D149en/D149en mice to CD207DTA mice. Unlike straight Irf8D149en/D149en mice, CD207-DTA::Irf8D149en/D149en mice did not have a
large increase in DP cDC2s when cDC1 generation was blocked (Figure 5A). Some CD103+ cDC1s
and cDC2s remained in the dMLN of these mice, presumably due to compensatory cDC development/survival when a large fraction of cDCs are deleted (Figure 5A). Remaining cDC1s expressed
canonical cDC1 makers such as XCR1 and CD36 and thus seem to be bona-fide cDC1s (Figure 5—
figure supplement 1D). cLP polyclonal Treg cell frequencies as well as the proportion of putative
commensal-specific HELIOSlo Treg cells were unchanged in CD207-DTA::Irf8D149en/D149en mice, indicating that substantial loss of CD103+ cDC1s and cDC2s does not broadly affect Treg cell development (Figure 5B). In contrast to Irf8D149en/D149en mice (Figure 3B), CD207-DTA::Irf8D149en/D149en mice
did not show significant decreases in Th1 and TBET+ Treg cells and only a minor, non-significant,
increase in colonic GATA3+ Th2 cells (Figure 5B), suggesting that effects of cDC1-deficiency on Teff
cell generation may be offset by the loss of DP cDC2s.
When we transferred CT2 and CT6 into CD207-DTA::Irf8D149en/ D149en mice to assess the antigenspecific contribution of CD103+ cDC1s and cDC2s to pTreg cell development, we observed no
decreases in Helicobacter-specific pTreg cells (Figure 5C,D). Both Foxp3– CT2 and CT6 showed
decreased cell activation by CTV dilution in CD207-DTA::Irf8D149en/D149en mice, in contrast to the
increased cell activation seen in Foxp3– CT6 cells in Irf8D149en/D149en mice (Figure 3D, Figure 5C,D).
To determine if pTreg cell differentiation of CT2 and CT6 in CD207-DTA::Irf8D149en/D149en mice was
conserved after trafficking to peripheral tissues, we analyzed CT2 and CT6 cells recovered from the
cLP 7 days after naı̈ve T cell transfer. Similar to the dMLN, CT2 and CT6 pTreg cell differentiation
were not decreased while Foxp3– cells showed trends of decreased antigen stimulation based on
CTV dilution (Figure 5—figure supplement 2A,B). As CD103+ cDC1s and cDC2s in CD207-DTA::
Irf8D149en/D149en mice were not completely absent, we wondered whether CT2 and CT6 pTreg cell
differentiation correlated with the loss of cDC subsets in the dMLN. Notably, the loss of CD103+
cDCs (cDC1 and/or DP) did not significantly correlate with decreases in pTreg cell induction
(Figure 5E, Figure 5—figure supplement 2C). Rather, we saw an increase in the percent of Foxp3+
CT6 cells with decreased CD103+ DC1s, which trended similarly for CT2. Thus, decreased antigen
presentation capability with decreased CD103+ cDC1s and cDC2s in vivo did not significantly impact
Helicobacter-specific pTreg cell differentiation. However, the maintenance of some CD103+ cDC1s
and cDC2 in CD207-DTA::Irf8D149en/D149en mice represents a caveat to the interpretation of the in
vivo data presented here.

Loss of cDC subsets does not markedly alter the colon bacterial
microbiome
Perturbations of the microbiota due to cDC subset loss could affect antigen-specific pTreg cell differentiation (Brown et al., 2019). We therefore performed 16S rRNA sequencing and amplicon
sequence variant (ASV) analysis of colonic bacteria. Shannon alpha diversity was unchanged in the
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Figure 5. CD103– CD11b+ cDC2s are sufficient for in vivo Helicobacter-specific peripheral regulatory T (pTreg) differentiation. (A) CD103+ cDC1s and
cDC2s are greatly reduced in the distal mesenteric lymph node (dMLN) of CD207-DTA::Irf8D149en/D149en mice. Representative fluorescence-activated cell
sorting (FACS) plot and quantification of migratory conventional dendritic cell (cDC) subsets in the dMLN of littermate Irf8+/D149en and CD207-DTA::
Irf8D149en/D149en mice (expt. = 7, n = 7). (B) The frequency of polyclonal pTreg cells is unchanged in CD207-DTA::Irf8D149en/D149en mice, but Th1 and
Figure 5 continued on next page
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Figure 5 continued
TBET+ Treg cells are decreased. Representative FACS plots and intracellular staining quantification of FOXP3, HELIOS, TBET, RORgt, and GATA3
expression in colon lamina propria (expt. = 3–4). (C and D) Helicobacter-specific T cell activation and Treg cell differentiation are not dramatically
altered in CD103+ cDC1 and cDC2-deficient mice. Congenically marked 5  104 naı̈ve CT2 (C) or 105 naı̈ve CT6 (D) were transferred into littermate
Irf8+/D149en and CD207-DTA::Irf8D149en/D149en mice and analyzed for Foxp3IRES-GFP or Thy1.1 expression and cell trace violet (CTV) dilution in the dMLN
after 7 days (expt. = 4 for both). (E) CT6 pTreg cell differentiation is inversely correlated with the number of CD103+ cDC1s and cDC2s in the dMLN.
Congenically marked 5  104 naı̈ve CT2 (left) or 105 naı̈ve CT6 (right) were transferred into littermate control, CD207-DTA, and CD207-DTA::Irf8D149en/
D149en
mice and analyzed after 7 days. CT2 and CT6 Foxp3IRES-GFP or Thy1.1 expression was compared to cDC subset numbers in the same dMLNs
(expt. = 2). Each dot represents an individual mouse. Mean ± SEM (A–D) or + SEM (A, right). p-values from Sidak’s multiple comparisons test (A,
middle), two-way ANOVA subset/genotype interaction (A, right); Student’s t-test (B, middle), Sidak’s multiple comparisons test (B, right); Student’s
t-test (C and D); R2 and p-value for nonzero slope (E); *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. The following figure supplements are available for
Figure 5—figure supplement 1 and Figure 5—figure supplement 2.
The online version of this article includes the following source data and figure supplement(s) for figure 5:
Source data 1. CD103+ cDC1s and cDC2s are greatly reduced in the distal mesenteric lymph node (dMLN) of CD207-DTA::Irf8D149en/D149en mice,
Figure 5A raw data.
Figure supplement 1. CD103– CD11b+ cDC2s are sufficient for in vivoHelicobacter-specific peripheral regulatory T (pTreg) differentiation.
Figure supplement 1—source data 1. Variable frequencies of CD103+ conventional dendritic cells (cDCs) in the distal mesenteric lymph
node (dMLN) of CD207-DTA::Batf3–/–mice, Figure 5—figure supplement 1A raw data.
Figure supplement 2. CD103– CD11b+ cDC2s are sufficient for in vivo Helicobacter-specific peripheral regulatory T (pTreg) differentiation.

cDC-subset deficient mice (Figure 6—figure supplement 1A). Additionally, NMDS analyses of bacterial community compositions by Bray–Curtis or UniFrac distances did not show obvious clustering
by genotype (Figure 6—figure supplement 1B), consistent with a nonsignificant PERMANOVA analysis. Finally, the frequencies of H. typhlonius and H. apodemus ASVs were not markedly changed by
cDC subset deficiency (Figure 6—figure supplement 1C). While additional samples would likely
improve power to detect differences in the microbiome due to cDC-subset deficiency, our data do
not support the hypothesis that microbial changes affected Helicobacter-specific pTreg cell
differentiation.

Loss of CD103+ cDC1s and cDC2s does not increase the tolerogenic
potential of migratory CD103– CD11b+ cDC2s in vivo
Our data collectively suggest that pTreg cell induction is not confined to a single cDC subset and
that migratory CD103– CD11b+ cDC2s are likely sufficient for Helicobacter-specific pTreg cell induction in vivo. However, it remained possible that after genetic deletion of CD103+ cDC1s and cDC2s,
the remaining CD103– CD11b+ cDC2s gain access to niches that facilitate their development into
‘tolerogenic’ cDCs. To assess this possibility, we quantified the expression of proteins and genes
reported to be Treg cell-inducing (Coombes et al., 2007; Hasegawa and Matsumoto, 2018;
Marie et al., 2005; Morris et al., 2003) in CD103– CD11b+ cDC2s from CD207-DTA::Irf8D149en/
D149en
mice. T cell activation-associated proteins (MHC Class II (IAb), CD80, CD86, CD40, PD-L1, and
PD-L2) were unchanged in CD103– CD11b+ cDC2s from CD207-DTA::Irf8D149en/ D149en mice (Figure 6—figure supplement 2A). Additionally, the activity of RALDHs, of which RALDH2 in CD103+
cDC1s and cDC2s has been shown to enhance pTreg cell generation in vitro (Coombes et al., 2007;
Sun et al., 2007), was unchanged in CD103– CD11b+ cDC2s from CD207-DTA::Irf8D149en/D149en mice
(Figure 6A). Finally, genes (Tgfb1–3, Itgb6, Itgb8) and proteins (TGFb1, CD51) associated with TGFb production and activation, a molecule that is critical for pTreg cell FOXP3 induction (Chen et al.,
2003), were not increased and for some genes (Tgfb2 and Tgfb3) were decreased in CD103–
CD11b+ cDC2s from CD207-DTA::Irf8D149en/D149en mice (Figure 6B,C). The integrins avb6 and avb8
activate TGF-b, and avb8 expression in cDC1s has been specifically associated with tolerance in the
intestines (Boucard-Jourdin et al., 2016; Morris et al., 2003; Travis et al., 2007). While our data
confirm previous studies showing preferential function of RALDH and expression of Itgb8 in cDC1s
(Boucard-Jourdin et al., 2016; Coombes et al., 2007; Sun et al., 2007) and Ido1 in CD103+
CD11b+ cDC2s (Matteoli et al., 2010), we found that other Treg cell inducing- and tolerance-associated genes and proteins such as CD51 (Itgav), Tgfb1, and Il10 were preferentially expressed in
CD103– CD11b+ cDC2s. However, the increased expression of Il10, Itgav, and Tgfb1 may be due to
the contamination of the CD103– CD11b+ cDC2 subset by macrophages (Figure 2—figure
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Figure 6. CD11b+ SP cDC2s are tolerogenic by ‘nature’, not ‘nurture’. (A) Retinal dehydrogenase (RALDH) activity as measured by Aldefluor is
unchanged in CD11b+ SP cDC2s in CD207-DTA::Irf8D149en/D149en mice deficient in CD103+ cDC1s and cDC2s (expt. = 2). (B) LAP and CD51 protein
expression is unchanged in CD11b+ SP cDC2s in CD207-DTA::Irf8D149en/D149en mice (expt. = 2). (C) Tgfb1, IL10, Itgb6, Itgb8, and Ido1 gene expression
are unchanged in CD11b+ SP cDC2s in CD207-DTA::Irf8D149en/D149en mice, while Tgfb2 and Tgfb3 gene expression are decreased (expt. = 2). Each dot
Figure 6 continued on next page
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Figure 6 continued
represents an individual mouse. Mean ± SEM shown (A–C). p-values from Tukey’s multiple comparisons test (A–C) using D-DCt values in (C); *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001.
The online version of this article includes the following source data and figure supplement(s) for figure 6:
Figure supplement 1. CD11b+ SP cDC2s are tolerogenic by ‘nature’, not ‘nurture’.
Figure supplement 1—source data 1. 16S rRNA sequencing of whole colon lumen feces of conventional dendritic cell (cDC)-deficient mice, Figure 6—
figure supplement 1B raw data.
Figure supplement 2. CD11b+ SP cDC2s are tolerogenic by ‘nature’, not ‘nurture’.

supplement 1A). These data therefore support the idea that each subset of cDCs may employ different mechanisms to induce pTreg cell development (Figure 6A–C, Figure 6—figure supplement
2A). We also analyzed the remaining CD103+ cDC1s and cDC2s in CD207-DTA::Irf8D149en/D149en
mice to determine if their expression of tolerogenic markers was altered. Remaining CD103+ cDC1s
and cDC2s showed significantly decreased CD86 expression and an increased trend of CD274 (PDL1) expression, suggesting that they may be more ‘immature’ compared to their wild-type counterparts (Figure 6—figure supplement 2B). Taken together, these data suggest that pTreg cell selection in the context of CD103+ cDC deletion is not due to ‘nurture’ of CD103– cDCs to become
tolerogenic but suggests that the ‘nature’ of CD103– CD11b+ cDC2s in normal mice is to induce Helicobacter-specific pTreg cell differentiation.

Antigen dose-dependent superiority of CD103+ cDC1s for in vitro
pTreg cell selection
Our in vivo data are in marked contrast with previous in vitro studies (Coombes et al., 2007;
Sun et al., 2007) regarding the importance of CD103+ DCs, which in their study included both
cDC1s and cDC2s. In vitro, DP cDC2s presenting Helicobacter antigens acquired in vivo were the
most efficient at inducing Foxp3 in CT2 and CT6 T cells (Figure 7—figure supplement 1A). However, the frequency of Foxp3+ cells was much lower than that seen in the in vivo T cell transfer studies (Figures 3–5), The variance in Foxp3 induction ex vivo may be attributed to the level of antigen
loaded in vivo, as Foxp3 upregulation was correlated with the extent of T cell stimulation by each
cDC subset as assessed by the frequency of CD25+ cells (Figure 7—figure supplement 1B).
To experimentally control the level of antigen presentation, we stimulated naı̈ve OT-II T cells in
vitro with varying concentrations of OVA peptide presented by sorted cDC subsets (Figure 2—figure supplement 1D, Figure 7A,B). Consistent with previous reports on the total CD103+ cDC population (Coombes et al., 2007; Sun et al., 2007), we found that CD103+ SP cDC1s were the most
efficient at inducing Foxp3 in naı̈ve OT-II T cells in vitro (Figure 7A). However, induction of Foxp3
varied according to TCR signal strength. At lower levels of TCR-stimulation with OVA peptide, all
subsets of cDCs were able to induce Foxp3 equivalently, whereas CD103+ CD11b– cDC1s were
more efficient at higher levels of antigen stimulation (Figure 7A). This was also true if CD25 was
used as a marker for T cell activation to control for possible differences in costimulation and MHC
Class II levels between cDC subsets (Figure 7B). Whether these similarities or differences between
cDC subsets observed in vitro reflect their ability to induce Foxp3 in vivo remains unclear. However,
this in vitro assay does not appear to inform on pTreg cell selection to Helicobacter in vivo, perhaps
due to uneven levels of antigen acquisition by each subset, reinforcing the need for in vivo studies of
cDC subsets and pTreg cell selection.

A recessive model of pTreg cell selection
Our data do not support a model in which a single cDC subset is critical for inducing pTreg cell
selection, and rather suggest that multiple cDC subsets are involved. However, the ability of multiple
cDC subsets to induce FOXP3 may be problematic for responses to infection or injury. Evidence suggests that cDC subsets may have unique capacities to induce effector T cell subsets (Durai and Murphy, 2016), supported by their different cytokine producing functions but also by their divergent
abilities to sense specific bacterial components; for example, MLN CD103+ CD11b– cDC1s have relatively high expression of Tlr9 and CD103+ CD11b+ cDC2s have relatively high expression of Tlr4,
Tlr6, and Nod2 (Esterházy et al., 2016). CD103+ CD11b+ cDC2s also express TLR5, which senses
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Figure 7. Conventional dendritic cell (cDC)-mediated peripheral regulatory T (pTreg) cell differentiation in vivo is recessive to effector T cell
development. (A) Migratory cDC induction of OT-II pTreg cells in vitro is dependent on T cell receptor (TCR) stimulation. Treg cell induction of OT-II
cells by migratory cDC subsets with varying concentrations of OVA323-339 peptide is shown (expt. = 5). (B) In vitro, CD103+ SP cDC1s have increased
ability to induce OT-II pTreg cells at higher levels of TCR activation (based on CD25 upregulation). Migratory cDC subsets were cultured with naı̈ve OTII T cells as in (A) (expt. = 5). (C) TA1 cognate antigens are presented by mesenteric lymph node (MLN) migratory dendritic cells. 1.5  103 TA1- or CT6expressing T cell hybrids were co-cultured in vitro with 5  104 ex vivo MLN migratory cDCs (MHCIIhi CD11cint). NFAT-GFP expression in hybrids was
analyzed after 40 hr (expt. = 2). (D) Expression of a Th1-inducing TCR (TA1) in CT6 cells dominantly inhibits CT6 pTreg cell differentiation in vivo. Naı̈ve
CT6 T cells were retrovirally transduced with either TA1 or a non-reactive control TCR (T7-2 or T9). Untransduced CT6, CT6 co-expressing TA1, or CT6
co-expressing T7-2 or T9 were transferred into each mouse; mice received either 5  104 of each TCR (closed shapes) or 2  105 of each TCR (open
shapes). Expression of Foxp3IRES-GFP or Thy1.1 and CXCR3 were quantified in the distal MLN (dMLN) after 7 days. Each dot represents the mean of
indicated experiments (A and B), an individual co-culture well (C), or an individual mouse (D). Mean ± SEM shown (A–D). p-values from mixed effects
analysis of repeated measures of DC subsets with Tukey’s multiple comparisons test (A and B); Tukey’s multiple comparisons test (C and D); *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001.
The online version of this article includes the following source data and figure supplement(s) for figure 7:
Source data 1. Migratory conventional dendritic cell (cDC) induction of OT-II peripheral regulatory T (pTreg) cells in vitro is dependent on T cell
receptor (TCR) stimulation, Figure 7A raw data.
Source data 2. In vitro, CD103+ SP cDC1s have increased ability to induce OT-II peripheral regulatory T (pTreg) cells at higher levels of TCR activation,
Figure 7B raw data.
Figure supplement 1. Conventional dendritic cell (cDC)-mediated peripheral regulatory T (pTreg) cell differentiation in vivo is recessive to effector T
cell development.
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flagellin and is likely important for Teff cell responses to pathogenic bacteria such as Salmonella
(Kinnebrew et al., 2012; Uematsu et al., 2008). We therefore hypothesized that pTreg cell selection is ‘recessive’, requiring all T cell-interacting antigen-presenting cDC subsets to be permissive to
pTreg cell selection such that activated T cells at a minimum retain the ability to upregulate FOXP3.
During inflammatory conditions, a subset of cDCs may then ‘dominantly’ induce fully differentiated
effector T cells via the production of cytokines that block FOXP3 induction, even if the T cells subsequently encounter cDCs that facilitate pTreg cell generation.
To test this hypothesis, we used adoptive transfer of modified CT2 or CT6 T cells into wild-type,
Helicobacter-colonized hosts, as the blockade of in vivo pTreg cell differentiation by Th1 differentiation has not been reported to our knowledge. First, we cultured naı̈ve Helicobacter-specific cells in
the presence of Th1- or Th2-polarizing conditions in vitro to model the possibility that pTreg cell differentiation in vivo would be dominantly inhibited by the presence of Th1- or Th2-inducing cytokines
during activation. After activation in Th1 or Th2 conditions in vitro, in vivo pTreg cell differentiation
of CT2 T cells was completely abrogated (Figure 7—figure supplement 1C). To address that in vitro
activation itself did not lead to an inability to undergo pTreg cell differentiation in vivo, we cultured
CT2 cells in ‘Th0’-inducing conditions, which permitted normal pTreg cell differentiation after adoptive transfer in vivo (Figure 7—figure supplement 1C). These data also show that in vitro T cell activation without the induction of Foxp3 (‘Th0’) does not result de facto in the generation of fully
differentiated CD44hi effector T cells that are no longer capable of becoming pTreg cells, consistent
with our previous observation that the frequency of Foxp3+ cells continues to increase after 1 week
in transferred transgenic T cells (Nutsch et al., 2016).
To address the possibility that in vitro Th1 differentiation does not mimic in vivo conditions, we
expressed a Th1-directing TCR (TA1) in CT6 T cells, hypothesizing that the TA1 TCR will engage
antigen in a Th1 environment not normally experienced by CT6 cells under homeostatic conditions.
We first confirmed that the stimulatory antigen for TA1, which is thus far uncharacterized, is presented by DCs in the MLN using T cell hybridoma cells expressing GFP under a minimal NFAT promoter (Ise et al., 2010). When TA1- or CT6-expressing hybrids were co-cultured with MLN
migratory DCs from Helicobacter-free mice, TA1 but not CT6-expressing hybrids were activated
(Figure 7C). Looking then in vivo, CT6 cells that co-expressed TA1, but not a non-reactive control
TCR, failed to induce Foxp3 but expressed the Th1 marker CXCR3 (Figure 7D). CT6 cells that coexpressed TA1 also proliferated more than cells that expressed a non-reactive control TCR, indicating that CT6 engagement on a ‘tolerogenic’ cDC was not sufficient to inhibit cell division (Figure 7—
figure supplement 1D). Taken together, these data support a ‘recessive’ model in which pTreg cell
differentiation is subdominant to a Th1 response in the same localized tissue environment.

Discussion
The generation of gut commensal-specific pTreg cells is a critical mechanism for maintaining gut
homeostasis, and yet the cDC subsets that present antigen to naı̈ve T cells and direct T cell development remain unclear (Mowat, 2018). Here, we provide direct evidence identifying the cDC subsets
that are capable of presenting Helicobacter antigens. Unexpectedly, we found that all migratory
cDC subsets, both CD103+ and CD103–, contained cells capable of presenting Helicobacter antigens
ex vivo. The use of genetic models with large reductions in specific cDC subsets supported the
notion that CD103+ cDC1s and cDC2s were neither required for antigen presentation nor pTreg cell
generation in vivo. These observations argue against the notion that a singular tolerogenic cDC subsets presents gut antigens and induces pTreg cell generation (Hasegawa and Matsumoto, 2018;
Scott et al., 2011; Takenaka and Quintana, 2017; Tanoue et al., 2016), and lend support to the
idea that CD103– CD11b+ cDC2s are important or redundant for intestinal pTreg cell induction
(Kim et al., 2018; Veenbergen et al., 2016). Our data also suggest a ‘recessive’ model in which all
gut cDC subsets are permissive to pTreg cell generation during homeostasis, but where pTreg cell
selection can be ‘dominantly’ blocked by the existence of pro-inflammatory cDCs during inflammation or infection, even when homeostatic pTreg cell inducing cDCs remain.
One issue with the study of intestinal cDC subsets in vivo is the limitation of the genetic tools
used for cDC subset depletion. For example, Batf3–/– mice have been used to deplete cDC1s, but
many cDC1s remain in mucosal-associated tissues in these mice (Tussiwand et al., 2015). Additionally, deletion of Batf3 in other cell types may affect immune cell homeostasis beyond loss of cDC1
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cells. Newer models such as the Xcr1DTR mouse appears to be a more efficient alternative to Batf3–/–
mice for depletion of cDC1s (Yamazaki et al., 2013). Similarly, Irf8D149en/D149en mice only lose IRF8
expression in cDC1 cells, resulting in specific loss of cDC1 development (Durai et al., 2019). However, there may still be some limitations. Xcr1DTR may not deplete immature cDC1s (5–10%) and
may deplete a small fraction (5%) of CD103+ CD11b+ cDC2s in the MLN (Yamazaki et al., 2013).
Also, longer term studies with diphtheria toxin are not possible due to the generation of neutralizing
antibodies. Our data suggest that Irf8D149en/D149en also does not completely block cDC1 generation
in the gut, specifically the colon. A direct experimental comparison of Xcr1DTR and Irf8D149en/D149en is
therefore needed. Nonetheless, we observed that the total number of cDC1s in Irf8D149en/D149en
mice was greatly reduced compared to control mice without grossly affecting Helicobacter-specific
pTreg cell differentiation in vivo.
Similarly, the elimination of CD103+ CD11b+ cDC2s has been achieved via Itgax-Cre mediated
deletion of Irf4 or Notch2, as well as CD207-DTA. However, we found the effects of these deletions
on Helicobacter-specific pTreg cell generation varied substantially, with Irf4 and CD207-DTA showing little to no effect and deletion of Notch2 in cDCs inhibiting pTreg cell generation (Nutsch et al.,
2016). Since all of these genetic models lead to a loss of DP cDC2s, our current interpretation of
these discrepant effects is that DP cDC2s are not required for pTreg cell selection and that the deletion of Notch2 in other cDC subsets leads directly or indirectly to a defect in pTreg cell induction.
However, we acknowledge that CD207-DTA depletion of DP cDC2s is not complete in the context
of cDC1 depletion, and that a caveat of these and other genetic models is that it remains possible
that the remaining cDCs in the targeted subset may be sufficient for pTreg cell induction. Thus,
these data provide a cautionary tale for studying cDC function using these Cre-deletion models that
were originally used to analyze cDC development and suggest that new genetic models are required
to better understand the role of DP and CD11b+ SP cDC2 subsets in vivo.
An unexpected observation from our data was that all migratory cDC subsets presented Helicobacter antigens. Research into acquisition of luminal antigens by cDCs has suggested that specific
cDC subsets may be specialized for this process. Small intestinal CD103+ cDC1s or cDC2s have been
reported to extend trans-epithelial dendrites into the intestinal lumen to phagocytose pathogenic
Salmonella typhimurium during infection (Farache et al., 2013). Goblet associated passages have
been shown to deliver soluble dietary antigens to lamina propria CD103+ cDC1s or cDC2s in the
small intestine (McDole et al., 2012). CD103+ SP cDC1s have also been shown to be uniquely capable of cross-presenting antigens from apoptotic intestinal epithelial cells, which could contain phagocytosed luminal antigens (Cerovic et al., 2015). Yet, to our knowledge, a direct assessment of the in
vivo loaded endogenous commensal antigens presented by cDC subsets in the MLN has not been
reported. Although our data shows that all cDC subsets acquire antigen, the loading may not be uniform, as we observed subtly different effects of cDC subset depletion on CT2 and CT6 T cell proliferation. This may be due to differences between H. typhlonius and H. apodemus colonization, or in
the specific proteins recognized by CT2 and CT6. Future studies are required to determine if antigen
loading on all cDC subsets is generalizable to other gut bacteria.
The lack of selectivity of Helicobacter antigens for presentation by a particular cDC subset, coupled with the in vivo observation that substantial deletion of CD103+ cDC1s and cDC2s does not
markedly impact pTreg cell selection to Helicobacter, favors the notion that Treg cell selection in
vivo utilizes redundant cDC subsets rather than specialized ‘tolerogenic’ CD103+ cDC1s and cDC2s.
While these genetic models of cDC subset deficiency have clearly been shown to impact the immune
system (Durai et al., 2019; Welty et al., 2013), we do acknowledge that the loss of CD103+ cDC1s
and cDC2s, while substantial, is not complete and therefore we cannot exclude the possibility that
the remaining CD103+ cDC1s and cDC2s are sufficient. Although we did not observe a correlation
of CT2 and CT6 Foxp3 induction with CD103+ cDC numbers (cDC1 or cDC2s), new tools with complete deletion of CD103+ cDC1s and cDC2s will be required to definitively address the role of these
cDCs in pTreg cell generation in vivo.
Our results showing that CD103+ cDC1s are more efficient than cDC2s for pTreg cell induction in
vitro is consistent with previous reports on the total CD103+ cDC population (Coombes et al.,
2007; Sun et al., 2007). It therefore remains possible that certain bacterial or food antigens in the
gut may utilize this quantitative difference between the cDC subsets in pTreg cell induction in vivo.
Although future studies are required, our data imply that these antigens would be present at high
dose and would be preferentially acquired by cDC1s. However, the fact that cDC1-deficient mice do
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not appear to suffer from spontaneous gut immunopathology (Welty et al., 2013) suggests that
these antigens do not represent a major component of gut tolerance.
Our data suggest that commensal-specific pTreg cell differentiation can take place when cDCs
carrying cognate antigen are permissive to pTreg cell induction such that they do not deliver a signal
that terminally differentiates T cells into a FOXP3– effector T cell lineage. This fits well with data suggesting that the MLN stroma environment is intrinsically pTreg cell-inducing (Cording et al., 2014;
Esterházy et al., 2019; Fletcher et al., 2015; Pezoldt et al., 2018), which would influence the function of all cDC subsets at homeostasis in the absence of inflammatory cues. In accordance with this
idea, other groups have found that the tolerogenic milieus of skin and tumors induce a pro-Treg
cell-inducing
gene
signature
that
is
common
across
migratory
cDC
subsets
(Anandasabapathy et al., 2014; Nirschl et al., 2017). It is notable that CD103– CD11b+ cDC2s did
not express factors associated with increased cDC-mediated Treg induction such as RALDH activity
or Ido1 and Itgb8 expression (Boucard-Jourdin et al., 2016; Coombes et al., 2007; Matteoli et al.,
2010; Sun et al., 2007), which may explain the decreased ability of CD103– CD11b+ cDC2s to promote Foxp3 induction in vitro compared to CD103+ cDC1s. This also implies that there may be additional cDC or environmental factors that promote Foxp3 induction in the gut.
We do not believe that every T:DC interaction during homeostasis is required to induce a binary
Treg vs T effector cell outcome. Even if the T cell does not upregulate FOXP3 after activation by the
cDC, the cells may adopt a ‘Th0’ phenotype which retains the ability to subsequently upregulate
FOXP3 or other lineage-specifying transcription factors. Support for this comes from our observation
that CNS1-deficient T cells, which show little to no upregulation of Foxp3 at 1 week, appear to
undergo induction of Foxp3 at later times points (Nutsch et al., 2016). Similarly, the frequency of
Foxp3+ cells continues to increase after 1 week of adoptive transfer of naı̈ve T cells, although this
may also be due to relative expansion (Nutsch et al., 2016). Finally, in vitro activated Foxp3– T cells
transferred in vivo can still undergo Foxp3 induction given the right TCR as long as the cells were
not exposed to Th1- or Th2-inducing cytokines in vitro. Thus, pTreg cell selection may be termed
‘recessive’ as all cDC subsets presenting antigen would be required to be permissive for this
process.
We predict that the homeostatic pTreg cell selection process can be disrupted by T cell encounter with cDCs expressing signals that induce effector phenotypes and block FOXP3 induction. As
proof of concept, we showed that TCR transgenic cells exposed to Th1 or Th2 cytokines in vitro no
longer undergo pTreg cell selection in vivo, confirming previous in vitro results (Caretto et al.,
2010; Wei et al., 2007). In addition, TCR transgenic cells co-expressing a Th1 TCR, which engages
cDCs other than that seen by the Helicobacter-specific TCR, also failed to upregulate Foxp3.
Together, these data suggest a model whereby pTreg cell selection by tolerogenic cDCs is ‘recessive’ to cDCs that dominantly induce effector T cell development. This mechanism provides a satisfying model for operation of the gut adaptive immune system. Anti-inflammatory pTreg production
would dominate during homeostatic conditions in the presence of typical commensal microbiota,
whereas pro-inflammatory effector T cells, and not pTreg cells, would emerge when a pathogen is
sensed. If antigen is carried by multiple cDC subsets, then naı̈ve antigen-specific T cells could potentially differentiate into multiple effector T cell subsets in the correct contexts. The result is a careful
balance between steady-state functional tolerance and focused anti-microbial responses that help
preserve gut function in the context of time-varying microbial populations.

Materials and methods
Key resources table
Reagent type
(species) or
resource
Antibody

Designation
Anti-mouse CD3e
(clone# 145–2 C11)
FITC, PE, and BV421

Source or
reference

Identifiers

Additional
information

Biolegend

100305/07/35

Dilution: 1:300

Continued on next page
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Continued
Reagent type
(species) or
resource

Designation

Source or
reference

Identifiers

Additional
information

Antibody

Anti-mouse/human
B220 (clone# RA36B2) APC/Cy7 and
A700

Biolegend

103223/31

Dilution: 1:750

Antibody

Anti-mouse CD19
(clone# 6D5) APC/Cy7

Biolegend

115529

Dilution: 1:750

Antibody

Anti-mouse I-Ab
(clone# AF6-120.1)
APC and PerCP/Cy5.5

Biolegend

116417/15

Dilution: 1:750

Antibody

Anti-mouse CD11c
(clone# N418)
PE/Cy7 and BV605

Biolegend

117317/33

Dilution: 1:750

Antibody

Anti-mouse/human
CD11b (clone#
M1/70) BV711

Biolegend

101241

Dilution: 1:750

Antibody

Anti-mouse CD103
(clone# 2E7) BV421

Biolegend

121421

Dilution: 1:300

Antibody

Anti-mouse CD4
(clone# RM4-5)
BV711, PE, and PB

Biolegend

100549/11/34

Dilution: 1:750

Antibody

Anti-mouse CD25
(clone# PC61) APC,
BV605, PerCP/Cy5.5,
and PE-Cy7

Biolegend

102011/35/29/15

Dilution: 1:750

Antibody

Anti-mouse/human
CD44 (clone# IM7)
APC/Cy7 and BV605

Biolegend

103027/47

Dilution: 1:750

Antibody

Anti-mouse CD62L
(clone# MEL-14)
APC/Cy7 and BV605

Biolegend

104427/37

Dilution: 1:750

Antibody

Anti-mouse FOXP3
(clone# FJK-16s) FITC

Thermo Fisher

11-5773-82

Dilution: 1:200

Antibody

Anti-mouse GATA3
(clone# 16E10A23) PE

Biolegend

653803

Dilution: 1:30

Antibody

Anti-mouse RORgt
(clone# B2D) APC

Thermo Fisher

17-6981-80

Dilution: 1:200

Antibody

Anti-mouse TBET
(clone# 4B10) PE/Cy7

Biolegend

644823

Dilution: 1:200

Antibody

Anti-mouse HELIOS
(clone# 22F6) A647

Biolegend

137208

Dilution: 1:200

Antibody

Anti-mouse CXCR3
(clone# CXCR3173) BV421

Biolegend

126521

Dilution: 1:300

Antibody

Anti-mouse
Thy1.1 (clone#
30-H12) PE/Cy7

Biolegend

105325

Dilution: 1:750

Antibody

Anti-mouse LAP
(clone# TW7-16B4)
BV421

Biolegend

141407

Dilution: 1:100

Antibody

Anti-mouse CD51
(clone# RMV-7) PE

Biolegend

104105

Dilution: 1:200

Antibody

Anti-mouse CD80
(clone# 16-10A1) APC

Biolegend

104713

Dilution: 1:750

Antibody

Anti-mouse CD86
(clone# GL-1) BV605

Biolegend

105037

Dilution: 1:300

Continued on next page

Russler-Germain et al. eLife 2021;10:e54792. DOI: https://doi.org/10.7554/eLife.54792

20 of 29

Research article

Immunology and Inflammation

Continued
Reagent type
(species) or
resource

Designation

Source or
reference

Identifiers

Additional
information

Antibody

Anti-mouse CD40
(clone# 3/23) APC

Biolegend

124611

Dilution: 1:750

Antibody

Anti-mouse CD273
(clone# TY25) APC

Biolegend

107210

Dilution: 1:300

Antibody

Anti-mouse CD274
(clone# 10F.9G2)
BV421

Biolegend

124315

Dilution: 1:300

Antibody

Anti-mouse XCR1
(clone# ZET) APC

Biolegend

148205

Dilution: 1:300

Antibody

Anti-mouse CD36
(clone# CRF D-2712) PE

Becton Dickinson

562702

Dilution: 1:200

Antibody

Anti-mouse CD45.1
(clone# A20) PE,
APC, and PE/Cy7

Biolegend

110707/14/29

Dilution: 1:750

Antibody

Anti-mouse CD45.2
(clone# 104) PE,
APC, PE/Cy7,
and A700

Biolegend

109807/14/29/21

Dilution: 1:750

Antibody

Anti-mouse VB6
(clone# RR4-7)
PE and APC

Biolegend

140003/5

Dilution: 1:750

Antibody

Anti-mouse Va2
(clone# B20.1)
APC/Cy7 and
PerCP/Cy5.5

Biolegend

127818/13

Dilution: 1:750

Antibody

Anti-mouse VB5
(clone# MR9-4) PE

Biolegend

139503

Dilution: 1:750

Antibody

Anti-mouse F4/80
(clone# BM8) PE/Cy7

Biolegend

123113

Dilution: 1:750

Antibody

Anti-mouse SIRPa
(clone# P84) A700

Biolegend

144021

Dilution: 1:750

Antibody

Anti-mouse CD24
(clone# M1/69) PE

Biolegend

101807

Dilution: 1:750

Antibody

Anti-mouse CD101
(clone# Moushi101) PE/Cy7

Thermo
Fisher

50-112-3316

Dilution: 1:300

Strain, strain
background
(Mus musculus)

OT-II TCR
transgenic mice

The Jackson
Laboratory (JAX)

#004194

Strain, strain
background
(Mus musculus)

Ccr7GFP knockin/
knockout mice

The Jackson
Laboratory (JAX)

#027913

Strain, strain
background
(Mus musculus)

Itgax-Cre
mice

The Jackson
Laboratory (JAX)

#008068

Strain, strain
background
(Mus musculus)

Irf4fl/fl mice

The Jackson
Laboratory (JAX)

#009380

Strain, strain
background
(Mus musculus)

CT2 TCR
transgenic mice

Nutsch et al., 2016

Strain, strain
background
(Mus musculus)

CT6 TCR
transgenic
mice

Nutsch et al., 2016

Continued on next page
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Continued
Reagent type
(species) or
resource

Designation

Source or
reference

Identifiers

Strain, strain
background
(Mus musculus)

Rag1–/– mice

The Jackson
Laboratory (JAX)

#002216

Strain, strain
background (Mus musculus)

Foxp3IRES-GFP
mice

The Jackson
Laboratory (JAX)

#006772

Strain, strain
background
(Mus musculus)

Foxp3IRES-Thy1.1
mice

Liston et al., 2008

Strain, strain
background (Mus musculus)

Irf8D149en/D149en
mice; formerly
Irf8 +32 5’–/–

Durai et al., 2019

Strain, strain
background
(Mus musculus)

Batf3–/– mice

Hildner et al., 2008

Strain, strain
background
(Mus musculus)

Zbtb46GFP mice

Satpathy et al., 2012

Strain, strain
background
(Mus musculus)

CD207-DTA
mice;
formerly
huLangerinDTA

Kaplan et al., 2005

Additional
information

Mice
Animal breeding and experiments were performed in a specific pathogen-free animal facility using
protocols approved by the Washington University Institutional Animal Care and Use Committee
(protocol #20170036). Littermates were used for all comparisons of control and cDC-deficient mice.
CT2, CT6, and OT-II transgenic mice were bred to Rag1–/– and Foxp3IRES-GFP (Lin et al., 2007) or
Foxp3IRES-Thy1.1 (Liston et al., 2008).

Adoptive transfer and harvest of T cells
Lymph nodes and spleens were harvested from congenically marked (Ly5.1, Ly5.2, or Ly5.1/2) CT2,
CT6, or OT-II transgenic mice. Naı̈ve T cells (CD4+ Foxp3– CD25– CD62Lhi CD44lo) were sorted on a
FACSAria IIu (Becton Dickinson) and stained with CTV (Thermo Fisher #C34571). 5  104 (CT2/OTII), or 105 (CT6) cells were retro-orbitally injected into 3–4-week-old mice on day 0 unless otherwise
noted. For OT-II transfer in an oral tolerance model, mice were gavaged with 50 mg of OVA (Sigma
#A5503) on days 1 and 2. CT2 and CT6 cells were analyzed by flow cytometry (Flowjo) in the dMLN
on day 7, while OT-II cells were analyzed from the whole MLN on day 8. For analysis of polyclonal
cLP T cells, colons were processed as in Nutsch et al., 2016. Briefly, colons were cleaned and incubated in RPMI (Thermo Fisher # SH3025502) with 3% bovine calf serum, 20 mM HEPES, dithiothreitol
(Sigma #43819), and EDTA for 20 min at 37˚C with constant stirring. Tissue was further digested with
28.3 mg/ml Liberase TL (Sigma #5401020001) and 200 mg/ml deoxyribonuclease I (Sigma #DN25),
with continuous stirring at 37˚C for 30 min. Digested tissue was forced through a Cellector tissue
sieve (Bellco Glass) and passed through a 40 mm cell strainer. Transcription factors were stained
using the FOXP3/Transcription Factor Staining Buffer Set (Thermo Fisher #00-5523-00).

Preparation of DCs
DCs were harvested from the dMLN of 3–5-week-old Ly5.1 Foxp3IRES-GFP mice in our colony for ex
vivo and fluorescence-activated cell sorting (FACS) experiments, and from cDC deficient mice for
qPCR experiments. dMLN were dissociated in RPMI containing 5% bovine calf serum, penicillin/
streptomycin, 1 mM sodium pyruvate, non-essential amino acids, 50 mM beta-mercaptoethanol, 65.8
mg/ml collagenase VIII (Sigma # C2139), and 0.2 U/ml dispase (Thermo Fisher # CB-40235) for 45
min at 37˚C with continuous stirring. For culture and qPCR, DCs were blocked in 10 mg/ml anti-
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CD16/CD32 (BioXCell #BE0307) and sorted using the following markers: migratory cDCs (CD3e–
B220– CD19– IAbhi CD11cint), resident cDCs (CD3e– B220– CD19– IAbint CD11chi), CD103+ SP (CD3e–
B220– CD19– IAbhi CD11cint CD103+ CD11b–), DP (CD3e– B220– CD19– IAbhi CD11cint CD103+
CD11b+), and CD11b+ SP (CD3e– B220– CD19– IAbhi CD11cint CD103– CD11b+). RALDH activity was
quantified using Aldefluor (Stemcell #01700).
Ex vivo cDC-T cell simulation assay cDCs with indicated phenotypes were sorted by flow cytometry from the dMLN of 10–15 mice naturally colonized by vertical transmission of H. typhlonius and H.
apodemus. 104 cDCs were cultured with 2.5  104 naı̈ve (CD4+ Foxp3– CD25– CD44lo CD62Lhi) CT2,
CT6, or OT-II T cells sorted from transgenic mice. Cells were cultured in 96-well U-bottom plates for
2 days at 37˚C in 200 ml complete DMEM (Thermo Fisher #SH3008101) with 10% FBS, glutamax, 50
mM beta-mercaptoethanol, and 1 mM sodium pyruvate (10 mM HEPES, non-essential amino acids,
and penicillin/streptomycin). H. typhlonius and H. apodemus were cultured as in Chai et al., 2017,
autoclaved, filtered, and quantified for protein concentration by Bradford protein assay. Where
noted, either 2 ng/ml of autoclaved H. typhlonius or 1.4 ng/ml of autoclaved H. apodemus was added
to individual cultures. Where noted, cDC:T cell cocultures were incubated with 0.025 mg/ml aMHC
Class II blocking antibody (a different clone from the non-blocking IAb antibody used to sort cDCs)
(BioXCell #BE010). For cultures with OT-II T cells, indicated concentrations of OVA323-339 were
added to cultures. For T cell hybridoma stimulation by ex vivo cDCs, 104 CT6 or TA1 hybridomas
were incubated with 104 ex vivo MLN cDCs as described above. Where noted, 20 mg/ml anti-CD3
(BioXCell BE0001-1) was added to each well as a positive control. qPCR cDCs with indicated markers
were sorted into lysis buffer and processed for RNA with the Nucleospin RNA XS kit (Machery-Nagel
740902). cDNA was synthesized with SuperScript III Reverse Transcriptase (ThermoFisher 18080085).
qPCR was carried out with Luminaris Color HiGreen qPCR Master Mix (ThermoFisher K0391) using a
LightCycler 480 (Roche) for real-time quantitative RT-PCR. Transcripts were normalized to Gapdh
and quantified in two technological replicates. Primer pairs used were: Gapdh (F: 5’-ACAAGATGG
TGAAGGTCGGTGTGA-3’, R: 5’-AGCTTCCCATTCTCAGCCTTGACT-3’) (Zhou et al., 2014), Tgfb1
(F: 5’-GCTACCATGCCAACTTCTGT-3’, R:5’-CGTAGTAGACGATGGGCAGT-3’) (Kuczma et al.,
2009), Tgfb2 (F: 5’-TCGACATGGATCAGTTTATGCG-3’, R: 5’-CCCTGGTACTGTTGTAGATGGA-3’)
(Li et al., 2013), Tgfb3 (F: 5’-CGAGTGGCTGTTGAGGAGA-3’, R: 5’-GCTGAAAGGTGTGACATGGA3’) (de Verteuil et al., 2014), Il10 (F: 5’-AGTGGAGCAGGTGAAGAGTG-3’, R: 5’-TTCGGAGAGAGG
TACAAACG-3’) (Kuczma et al., 2009), Itgb6 (F: 5’-AAACGGGAACCAATCCTCTGT-3’, R: 5’-GCTTC
TCCCTGTGCTTGTAGG-3’) (Tatler et al., 2016), Itgb8 (F: 5’-CTGAAGAAATACCCCGTGGA-3’, R:
5’-ATGGGGAGGCATACAGTCT-3’) (Melton et al., 2010), Ido1(F: 5’-GAAGGATCCTTGAAGACCAC-3’, R: 5’-GAAGCTGCGATTTCCACCAA-3’) (Orabona et al., 2006).

16S rRNA sequencing
Fecal DNA was purified via column (Zymogenetics) and used in triplicate PCR of the bacterial V4
hypervariable region of 16S rRNA using barcoded primers described previously (Caporaso et al.,
2011). PCR products were sequenced using the Illumina MiSeq platform (2  250 bp paired end
reads), and ASVs and taxonomy including species designations if possible (silva 1.32) determined by
dada2 (Callahan et al., 2016). ASV data were analyzed by phyloseq (v1.32), vegan (v2.4), and
DESeq2 (v.1.28) in R (3.6).

In vitro polarization and transduction of T cells
24-well plates were coated with 10 mg/ml anti-CD3e (BioXCell BE0001-1) overnight at 4˚C. Wells
were washed with PBS and plated with 5–15  105 naı̈ve CT6 T cells in D10 and 1 mg/ml anti-CD28
(BioXCell BE0015-1) in Th0 conditions: 10 mg/ml anti-TGFb (BioXCell BE0057), 5 mg/ml anti-IL12 (BioXCell BE0052), 5 mg/ml anti-IFNg (BioXCell BE0054), and (5 mg/ml anti-IL4 (BioXCell BE0045)); Th1polarizing conditions: 10 ng/ml IL-12 (Peprotech #210–12); or Th2-polarizing conditions: 10 ng/ml IL4 (Peprotech #214–14). For in vitro polarization experiments, naı̈ve CT2 cells were plated on antiCD3e and cultured for 48 hr in Th0 or Th1 conditions, after which 1.5  105 cells were injected into
each host. For TCR transduction, TCRa chains utilized were TA1: TRAV14-3*01 CDR3 AASETGNTGKLI; T7-2: TRAV7-4*01 CDR3 AASEHWSNYQLI; and T9-1: TRAV9-1*02 CDR3 AVSAPNTNKVV. TCRa
chain retroviral transduction was performed as described in Hsieh et al., 2004 using TransIT-293
(Thermo Fisher # MIR2700). Note that the transduced cells all share the same original TCli TCRb
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chain (Hsieh et al., 2004). CT6 cells were plated on anti-CD3 in Th0 media, transduced 27 hr later,
and left to rest in Th0 media for 48–66 hr. Foxp3– cells were then sorted for TA1-transduced
(TdTomato+), control TCR-transduced (Thy1.1+), or untransduced cells. 5  104 (co-injection of transduced TCRs totaling 1.5  105 T cells per mouse) or 2  105 (injection of single transduced TCR plus
untransduced control cells) of each TCR were injected into each host. T cell hybridomas expressing
GFP under a minimal NFAT promoter (Ise et al., 2010) were retrovirally transduced with CT6 or TA1
TCRa chains as previously described (Chai et al., 2017; Lathrop et al., 2011).

Statistical analysis
Graphpad Prism v7 was used for statistical and graphical analysis unless noted. CTV division index
was obtained by manually defining CTV peaks for each cell population and using the formula
Pi Ni
ði Þ
P0i N2i i , where (i) = the maximum number of cell divisions in the population and (N) = the number of
ð Þ
0 2i
cells in a given CTV peak (i). Student’s t-test was used for between-subject analyses with two groups.
One-way ANOVA with Tukey’s multiple comparisons tests was used for between-subjects analysis
with greater than two groups and one independent variable. Two-way ANOVA with Sidak’s multiple
comparisons tests was used for between-subjects analysis with greater than two groups and two
independent variables. Where stated, the mixed effects model with Tukey’s multiple comparisons
tests were used instead of two-way ANOVA for repeated measures data with missing values. For in
vivo experiments, each dot represents data from an individual host. Bars indicate mean ± SEM.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
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